United States

Profile: Bio-Techne Corp (TECH.OQ)

TECH.OQ on NASDAQ Stock Exchange Global Select Market

16 Aug 2019
Change (% chg)

$4.72 (+2.45%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Bio-Techne Corporation, incorporated on July 17, 1981, develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Company operates through two segments: Protein Sciences and Diagnostics and Genomics.

Protein Sciences segment

The Protein Sciences reporting segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and reagents, to the biotechnology community. The Protein Sciences segment also provides an array of platforms useful in various areas of protein analysis.

Diagnostics and Genomics segment

The Diagnostics and Genomics reporting segment provides blood chemistry and blood gas quality controls, hematology instrument controls, diagnostics immunoassays and other bulk and custom reagents for the in vitro diagnostic market. The Diagnostics and Genomics segment also develops and commercializes in situ hybridization products and exosome-based diagnostics for various pathologies, including prostate cancer.

Company Address

Bio-Techne Corp

614 McKinley Pl NE
MINNEAPOLIS   MN   55413-2610
P: +1612.3798854
F: +1612.6564400

Company Web Links